Two years of treatment with the recombinant grass pollen allergy vaccine BM32 induces a continuously increasing allergen-specific IgG4 response.
Eckl-Dorna J, Weber M, Stanek V, Linhart B, Ristl R, Waltl EE, Villazala-Merino S, Hummel A, Focke-Tejkl M, Froeschel R, Neubauer A, Henning R, Perkmann T, Valenta R, Niederberger V.
Eckl-Dorna J, et al. Among authors: valenta r.
EBioMedicine. 2019 Dec;50:421-432. doi: 10.1016/j.ebiom.2019.11.006. Epub 2019 Nov 28.
EBioMedicine. 2019.
PMID: 31786130
Free PMC article.